1st Quarter - Report

KOUNTOUPES DENHAM CARR & REID, LLC for TEVA PHARMACEUTICALS USA, INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$20,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 20, 2018 $20,000 Replaced
1st Quarter - Termination Apr 20, 2018 $20,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Provisions affecting the Medicaid rebate program included in the Bipartisan Budget Act of 2015.

Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as the indirect parent of Teva Pharmaceuticals USA Inc., has an interest in the issues listed.

LobbyistCovered position, as disclosed
JULIE HERSHEY CARR —
LISA KOUNTOUPES —
DAVID PAUL PELUSO —
ROSE SULLIVAN (LISTED IN ERROR) —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Proposals related to affordability and pricing of pharmaceuticals including issues related to H. R. 2212 and S. 974, CREATES Act of 2017; H. R. 2051 - FAST Generics Act.

Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as the indirect parent of Teva Pharmaceuticals USA Inc., has an interest in the issues listed.

LobbyistCovered position, as disclosed
JULIE HERSHEY CARR —
LISA KOUNTOUPES —
DAVID PAUL PELUSO —
ROSE SULLIVAN (LISTED IN ERROR) —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2051 (115th), S. 974 (115th), H.R. 2212 (115th)

Pharmacy PHA

Proposals related to affordability and pricing of pharmaceuticals including H. R. 2212 and S.974 Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; H. R. 2051 - FAST Generics Act.

Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as the indirect parent of Teva Pharmaceuticals USA Inc., has an interest in this issues listed.

LobbyistCovered position, as disclosed
JULIE HERSHEY CARR —
LISA KOUNTOUPES —
DAVID PAUL PELUSO —
ROSE SULLIVAN (LISTED IN ERROR) —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2051 (115th), H.R. 2212 (115th), S. 974 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.